Skip to Main Content

Author Details

Mariam O Fofana
Yale School of Public Health
2008
21
11
Wade Schulz (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
38070701Extensive transmission of SARS-CoV-2 BQ.1* variant in a population with high levels of hybrid immunity: A prevalence survey.Int J Infect Dis2024
34127527Time and time again: the reincarnations of coerced sterilisation.J Med Ethics2022
36454733Association between primary or booster COVID-19 mRNA vaccination and Omicron lineage BA.1 SARS-CoV-2 infection in people with a prior SARS-CoV-2 infection: A test-negative case-control analysis.PLoS Med2022
36074784Structural factors associated with SARS-CoV-2 infection risk in an urban slum setting in Salvador, Brazil: A cross-sectional survey.PLoS Med2022
35194620Structural factors contributing to SARS-CoV-2 infection risk in the urban slum setting.medRxiv2022
33370211Decolonising global health in the time of COVID-19.Glob Public Health2021
34579188Willingness to Get the COVID-19 Vaccine among Residents of Slum Settlements.Vaccines (Basel)2021
27956422A Multistrain Mathematical Model To Investigate the Role of Pyrazinamide in the Emergence of Extensively Drug-Resistant Tuberculosis.Antimicrob Agents Chemother2017
28539499Reply to Anthony et al., "Protecting Pyrazinamide, a Priority for Improving Outcomes in Multidrug-Resistant Tuberculosis Treatment".Antimicrob Agents Chemother2017
26220909Development of global health education at Johns Hopkins University School of Medicine: a student-driven initiative.Med Educ Online2015
26409276The Distribution of Fitness Costs of Resistance-Conferring Mutations Is a Key Determinant for the Future Burden of Drug-Resistant Tuberculosis: A Model-Based Analysis.Clin Infect Dis2015
26597127Burden of transmitted multidrug resistance in epidemics of tuberculosis: a transmission modelling analysis.Lancet Respir Med2015
24816692Population-level impact of shorter-course regimens for tuberculosis: a model-based analysis.PLoS One2014
25734143Drivers and trajectories of resistance to new first-line drug regimens for tuberculosis.Open Forum Infect Dis2014
25090665Hazardous intersections: race, ethnicity, and medicine.Virtual Mentor2014
23575322Cost-effectiveness of novel first-line treatment regimens for tuberculosis.Int J Tuberc Lung Dis2013
239377792012 winning essay. Joey knows best? Balancing conflicts and defending a childâ¿¿s best interest in difficult clinical decisions.Virtual Mentor2013
23988563The spectre of race in American medicine.Med Humanit2013
21068674The clinical impact and cost-effectiveness of routine, voluntary HIV screening in South Africa.J Acquir Immune Defic Syndr2011
19620143When to start antiretroviral therapy in resource-limited settings.Ann Intern Med2009
18422445Scaling up antiretroviral therapy in South Africa: the impact of speed on survival.J Infect Dis2008
  • 1 - 21 of 21

Recommended Authors

Yelena Malyuta
Rhode Island Public Health Institute
Career Start Year 2018
Number of shared co-authors 0
Maria Mazzitelli
Padua University Hospital
Career Start Year 2016
Number of shared co-authors 0
Guohai Zhou
Center for Clinical Investigation, Brigham and Women's Hospital
Career Start Year 2014
Number of shared co-authors 0
Adovich S Rivera
Kaiser Permanente Southern California
Career Start Year 2014
Number of shared co-authors 0
Onyema Ogbuagu
Yale School of Medicine, Yale University
Career Start Year 2014
Number of shared co-authors 4
Benjamin M Althouse
University of Washington
Career Start Year 2010
Number of shared co-authors 1
Abraham D Flaxman
Institute for Health Metrics and Evaluation, University of Washington
Career Start Year 2010
Number of shared co-authors 1
Mathew V Kiang
Stanford University School of Medicine
Career Start Year 2010
Number of shared co-authors 0
Kate Zinszer
School of Public Health, Universite de Montreal
Career Start Year 2010
Number of shared co-authors 0
Devan Jaganath
University of California san francisco
Career Start Year 2009
Number of shared co-authors 0
Nahid Bhadelia
Boston University
Career Start Year 2007
Number of shared co-authors 1
Allison DeLong
School of Public Health, Brown University
Career Start Year 2007
Number of shared co-authors 0
David M Brett-Major
College of Public Health, University of Nebraska Medical Center
Career Start Year 2006
Number of shared co-authors 0
Diya Surie
Centers for Disease Control and Prevention
Career Start Year 2004
Number of shared co-authors 0
Frederique Jacquerioz
Geneva Center for Emerging Viral Diseases, Geneva University Hospitals
Career Start Year 2003
Number of shared co-authors 0
Edward J Mills
McMaster University
Career Start Year 2001
Number of shared co-authors 1
Scarlett L Bellamy
Dornsife School of Public Health, Drexel University.
Career Start Year 2000
Number of shared co-authors 0
Sanjay Basu
The Pirbright Institute
Career Start Year 2000
Number of shared co-authors 4
Sean Philpott
Clarkson University
Career Start Year 1999
Number of shared co-authors 0
Susanne May
University of Washington
Career Start Year 1998
Number of shared co-authors 0
Ran D Balicer
Clalit Health Services, Ben Gurion University
Career Start Year 1998
Number of shared co-authors 0
Thomas Dobbs
University of Mississippi Medical Center
Career Start Year 1998
Number of shared co-authors 0
Sonia Jain
University of California San Diego
Career Start Year 1997
Number of shared co-authors 0
Bisola O Ojikutu
Massachusetts General Hospital
Career Start Year 1996
Number of shared co-authors 1
Salmaan Keshavjee
Harvard Medical School
Career Start Year 1996
Number of shared co-authors 2
Robert E Weiss
Fielding School of Public Health, University of California Los Angeles
Career Start Year 1992
Number of shared co-authors 0
Elizabeth J Carter
Warren Alpert School of Medicine at Brown University
Career Start Year 1990
Number of shared co-authors 0
Ravi Jhaveri
Northwestern University, Feinberg Northwestern School of Medicine
Career Start Year 1988
Number of shared co-authors 0
Sean Cahill
The Fenway Institute
Career Start Year 1984
Number of shared co-authors 0
Arthur Reingold
University of California berkeley
Career Start Year 1971
Number of shared co-authors 2

Collaborators

Albert I Ko
Instituto Goncalo Moniz, Yale School of Public Health
Co-authored papers 5
Kenneth A Freedberg
Co-authored papers 3
Rochelle P Walensky
Massachusetts General Hospital
Co-authored papers 3
Ari Paltiel
Yale School of Public Health
Co-authored papers 3
Derek A T Cummings
University of Florida
Co-authored papers 3
Matt D T Hitchings
College of Public Health and Health Professions, University of Florida
Co-authored papers 2
Elsio A Wunder
Yale School of Public Health
Co-authored papers 2
Akiko Iwasaki
Yale University
Co-authored papers 1
Fred Warner
Yale School of Medicine
Co-authored papers 1
Chelsea Duckwall
Yale School of Public Health
Co-authored papers 1
Jason R Andrews
Stanford University
Co-authored papers 1
Erendira C Di Giuseppe
Yale School of Public Health
Co-authored papers 1
Otavio T Ranzani
Heart Institute (InCor), Faculdade de Medicina, Universidade de Sao Paulo
Co-authored papers 1
Nathan Price
Yale School of Medicine
Co-authored papers 1
Julio Silva
Yale University School of Medicine
Co-authored papers 1
Peri Sosensky
Yale School of Public Health
Co-authored papers 1
Andreas Coppi
Center for Outcomes Research and Evaluation, Yale-New Haven Hospital
Co-authored papers 1
Alexander J Robertson
Yale School of Public Health
Co-authored papers 1
Ryan Borg
Yale School of Public Health
Co-authored papers 1
Wade Schulz (CM4AI)
Yale University
Co-authored papers 1
Margaret L Lind
Yale School of Public Health
Co-authored papers 1
Julio Croda
Federal University of Mato Grosso do Sul
Co-authored papers 1
M Catherine Muenker
Yale School of Public Health
Co-authored papers 1
Natalie E Dean
College of Public Health and Health Professions, University of Florida
Co-authored papers 1
Release 1.2